Fenimore Christopher R. bought REGN
December 5, 2025 · Form 4 insider transaction
Fenimore Christopher R. bought 3,027 shares of Regeneron Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,027
Price
$0.00
Total value
N/A
InsiderFenimore Christopher R.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 5, 2025
Filing dateDecember 9, 2025
Shares owned after19,292
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 5, 2027 and 50% on December 5, 2029.